Pages that link to "Q53296857"

The following pages link to Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer's disease. (Q53296857):

Displaying 14 items.

• Structural and functional analysis of novel human cytochrome C targets in apoptosis (Q28387284) (← links)
• MicroRNA-related cofilin abnormality in Alzheimer's disease (Q33778743) (← links)
• Polymorphisms of glucose-regulated protein 78 and risk of colorectal cancer: a case-control study in southwest China (Q34789655) (← links)
• GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients. (Q35432445) (← links)
• Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives. (Q35709838) (← links)
• Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics (Q35852564) (← links)
• Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese Han population (Q36661245) (← links)
• Pharmacogenomics and therapeutic strategies for dementia (Q37592250) (← links)
• Genomics and pharmacogenomics of dementia (Q37780790) (← links)
• Proteomic differences in brain vessels of Alzheimer's disease mice: Normalization by PPARγ agonist pioglitazone. (Q46528028) (← links)
• Significance of functional GRP78 polymorphisms in predicting the onset of type 2 diabetic peripheral neuropathy in Chinese population (Q51280816) (← links)
• Revisiting the frontiers of pharmacogenomics of colon cancer. (Q54560326) (← links)
• Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. (Q55266735) (← links)
• Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population (Q58565054) (← links)